WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

CASE STUDY OF STARGARDT DISEASE

Dhruva R. Dabhi*

.

Abstract

Stargardt disease is the most common form of juvenile macular degeneration. Clinically, it is characterized by pisciform flecks at the level of the retinal pigment epithelium and a bull's-eye maculopathy. Inheritance is usually autosomal recessive, although dominantly inherited case have been described. Both sexes are affected equally. Even though significant research is taking place in this area, no treatment is available till date for this disease in contemporary science. In Ayurveda by considering the visual disturbance & field defect, this disease can be included under drishtigata rogas explained by Acharya Sushruta, Pitta vidagdha drishti is one among them, which holds more appropriate to define this clinical condition. As there is no common line of management following in these types of diseases in Ayurveda, an attempt has been made to explain the case treated as per the Ayurvedic principles. This study describes diagnosed as Stargardt‟s macular degeneration & underwent Ayurvedic treatment for one and half year. By executing Ayurvedic treatment the quality of the vision distant & near acuity is moderate improved.

Keywords: Stargardt?s disease, drishtigata roga, Tarpana.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More